Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-004083
Filing Date
2003-03-28
Accepted
2003-03-28 17:24:04
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AAIPHARMA INC. g81586e10vk.htm 10-K 1363715
3 SUBSIDIARIES OF AAIPHARMA, INC. g81586exv21.txt EX-21 816
4 CONSENT OF INDEPENDENT AUDITORS g81586exv23.htm EX-23 1374
5 RISK FACTORS g81586exv99w1.txt EX-99.1 45015
6 SECTION 906 CERTIFICATION OF CHIEF SCIENTIFIC OFF. g81586exv99w2.txt EX-99.2 3318
7 SECTION 906 CERTIFICATION OF CEO g81586exv99w3.txt EX-99.3 3212
8 SECTION 906 CERTIFICATION OF CFO g81586exv99w4.txt EX-99.4 3106
  Complete submission text file 0000950144-03-004083.txt   1422960
Mailing Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405
Business Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405 9102547000
AAIPHARMA INC (Filer) CIK: 0001013243 (see all company filings)

EIN.: 042687849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21185 | Film No.: 03626361
SIC: 8734 Services-Testing Laboratories